Form 8-K - Current report:
SEC Accession No. 0001171843-24-004218
Filing Date
2024-07-29
Accepted
2024-07-29 16:15:00
Documents
15
Period of Report
2024-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_072924.htm   iXBRL 8-K 15302
2 PRESS RELEASE exh_991.htm EX-99.1 561218
  Complete submission text file 0001171843-24-004218.txt   807583

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
17 EXTRACTED XBRL INSTANCE DOCUMENT f8k_072924_htm.xml XML 3316
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 241152541
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)